PROTOCOL #2 PHASE II STUDY OF ADENOVIRUS/PSA VACCINE IN MEN WITH HORMONE - REFRACTORY PROSTATE CANCER Food and Drug Administration (FDA) Investigational New Drug (IND) #9706 Department of Defense, Prostate Cancer Research Program A-14059.2 Version 42 – January 2 7, 2015 Co-Principal Investigators David M. Lubaroff, Ph.D.1 Daniel Vaena, MD Department of Urology Department of Internal Medicine University of Iowa University of Iowa 375 Newton Road 200 Hawkins Drive Iowa City, IA 52242 Iowa City, IA 52242 tel: 319-335-8423 tel: 319-356-3944 fax: 319-353-4556 fax: 319-353-8 377 e-mail: david- lubaroff@uiowa.edu e- mail: daniel -vaena@uiowa.edu Co-Inves tigators James A.